posted on 2020-07-15, 04:36authored byEsther Moreno, Juan M. Rosa-Rosa, Tamara Caniego-Casas, Ignacio Ruz-Caracuel, Cristian Perna, Carmen Guillén, José Palacios
Additional file 1. Immunohistochemistry: Clones and criteria used for the interpretation. Massive parallel sequencing: Description of the NGS panel. Sanger sequencing: Primers used and variants obtained from Sanger sequencing.
Funding
Instituto de Salud Carlos III CIBERONC Fundación Científica Asociación Española Contra el Cáncer